Seattle Genetics acquisition of Cascadian Therapeutics - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

IBM Corporation and Lam Research Corporation launch five-year collaboration to enable sub-1nm semiconductor logic scaling

The sub-1nm race is heating up and IBM and Lam Research just made their move

Representative image showing an oil tanker under attack in the Strait of Hormuz as tensions involving Iran’s Islamic Revolutionary Guard Corps raise fears of a major supply disruption that analysts warn could push global oil prices toward $200 per barrel.

Iran: Get ready for $200 oil. IRGC fires on more ships in the Gulf

Haleon plc invests £65M in Shanghai oral health plant as China becomes central to its global growth strategy

Haleon (NYSE, LSE: HLN) bets on China’s oral health boom with £65m Shanghai manufacturing facility

Could subcutaneous PD-1 therapy reshape oncology treatment logistics in China?

Read More

2 minute read

Pharma Industry News

Seattle Genetics to acquire Cascadian Therapeutics for $614m to bolster oncology portfolio

Seattle Genetics, a leader in oncology biotechnology, has announced the acquisition of Cascadian Therapeutics for approximately $614 million,…

February 3, 2018

web analytics